← Leaderboards
David Mann
Vascular Biosciences
$1,149,127
Attributed
$1,149,127
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $401.6K · FY2014–16$500K$375K$250K$125K$0
'14
'15
'16
Funding mix
By agency
NIH$1,149,127 · 1
By mechanism
N01$1,149,127 · 1
Top collaborators
No co-investigators on record.
Most similar at Vascular Biosciences
Same institution · by research overlap
- Masanobu Komatsu$5,846,234
Others in their field
Top investigators on “Vascular Endothelium”
- Jan E Schnitzer · Sidney Kimmel Cancer Center$30,139,798
- Michael Simons · Yale University$25,641,903
- Douglas R Seals · University Of Colorado$24,153,936
- Asrar B. Malik · University Of Illinois At Chicago$22,482,141
- Vladimir R Muzykantov · University Of Pennsylvania$21,989,714
- Luisa Iruela-Arispe · Northwestern University$21,370,881
Research focus
Vascular EndotheliumAnimal ModelSymptomsVascular DiseasesAdjuvantBlood VesselsContractsCyclic PeptidesDiagnosticDrug TargetingEffective InterventionInnovationLungLung DiseasesMedicalModalityNational Heart, Lung, And Blood InstituteNovel StrategiesPeptidesPharmaceutical PreparationsProduct DevelopmentProgramsPulmonary Arterial HypertensionPulmonary Artery Structure
Grant awards (3)
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY$385,534
N01 · FY2016 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY$401,635
N01 · FY2015 · HL · contact PI
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY$361,958
N01 · FY2014 · HL · contact PI